BARALDI, Pier Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 30.268
EU - Europa 9.509
AS - Asia 6.866
SA - Sud America 386
AF - Africa 55
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 27
Totale 47.142
Nazione #
US - Stati Uniti d'America 30.157
CN - Cina 3.380
DE - Germania 2.850
UA - Ucraina 2.243
TR - Turchia 1.705
SG - Singapore 1.319
GB - Regno Unito 1.005
IT - Italia 969
SE - Svezia 801
FI - Finlandia 589
RU - Federazione Russa 441
BR - Brasile 331
FR - Francia 163
VN - Vietnam 117
PL - Polonia 114
BE - Belgio 98
CA - Canada 83
NL - Olanda 72
IN - India 65
HK - Hong Kong 44
CZ - Repubblica Ceca 37
KR - Corea 32
JP - Giappone 31
ID - Indonesia 30
MX - Messico 27
MA - Marocco 25
AU - Australia 24
EU - Europa 24
LT - Lituania 23
IR - Iran 22
TW - Taiwan 21
CL - Cile 18
PK - Pakistan 18
ZA - Sudafrica 18
IL - Israele 16
AT - Austria 14
IQ - Iraq 14
AR - Argentina 13
CO - Colombia 12
RO - Romania 10
NO - Norvegia 9
BD - Bangladesh 8
CH - Svizzera 8
HU - Ungheria 8
MY - Malesia 8
UZ - Uzbekistan 8
ES - Italia 7
GR - Grecia 7
IE - Irlanda 7
NZ - Nuova Zelanda 7
MD - Moldavia 6
NP - Nepal 6
BG - Bulgaria 5
PT - Portogallo 5
TN - Tunisia 5
HR - Croazia 4
JO - Giordania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EG - Egitto 3
PE - Perù 3
PS - Palestinian Territory 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
LU - Lussemburgo 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
HN - Honduras 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 47.142
Città #
Woodbridge 3.792
Fairfield 3.594
Jacksonville 2.451
Houston 2.445
Chandler 2.077
Ashburn 2.045
Ann Arbor 1.914
Seattle 1.499
Wilmington 1.382
Santa Clara 1.381
Cambridge 1.093
Singapore 994
Izmir 799
Nanjing 772
Beijing 543
Princeton 512
Boardman 399
San Diego 322
Shenyang 266
Ferrara 265
Nanchang 213
Milan 209
Shanghai 207
Los Angeles 162
New York 161
Hebei 158
San Mateo 154
Bremen 144
Addison 142
Tianjin 141
Changsha 140
Jiaxing 122
Helsinki 119
Dearborn 114
Dong Ket 114
Jinan 106
Warsaw 104
Brussels 97
Falkenstein 96
Philadelphia 88
London 87
Falls Church 86
Norwalk 83
Redwood City 78
Munich 77
Kunming 76
Zhengzhou 70
Mountain View 59
Guangzhou 52
Ningbo 50
Auburn Hills 47
Orange 47
Verona 43
Amsterdam 38
Des Moines 37
Frankfurt am Main 37
Indiana 37
Taizhou 36
Toronto 36
Hong Kong 34
Lanzhou 32
Tappahannock 28
Hangzhou 27
Chicago 26
Paris 26
Jakarta 25
Washington 25
Ottawa 24
Düsseldorf 22
Mcallen 22
Redmond 22
São Paulo 22
Taipei 21
Augusta 20
Haikou 20
Montréal 20
Brno 19
Duncan 15
Leawood 15
Hefei 14
Kilburn 14
San Francisco 14
Rome 13
Weihai 13
Xian 13
Bari 12
Belo Horizonte 12
Fuzhou 12
Monmouth Junction 12
Espoo 11
Olomouc 11
Yellow Springs 11
Ardabil 10
Marrakesh 10
Taiyuan 10
Baghdad 9
Chiswick 9
Corvallis 9
Guarulhos 9
Mumbai 9
Totale 33.114
Nome #
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 370
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 354
1,4-Diketones via Isoxazole Intermediates 324
1,2,3-triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new class of A(2A) adenosine receptor antagonists 310
null 227
A glance at adenosine receptors: Novel target for antitumor therapy 207
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 178
A new, efficient synthesis of muscimol (5-ammoniomethylisoxazol-3-olate). 173
A facile, efficient synthesis of 2-substituted-4-hydroxy-2-cyclopenten-1-ones 171
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 169
The A3 adenosine receptor: history and perspectives 168
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 165
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 165
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 162
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 161
Azaprostaglandin Analogues. Synthesis and Biological Properties of 11-Azaprostaglandin Derivatives 160
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 160
A3 adenosine receptor antagonists: History and future perspectives 160
3,5-Disubstituted isoxazoles as a latent aldol moiety: application to the synthesis of (±)-[6]-gingerol. 157
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 157
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 155
Design, Synthesis, DNA Binding, and Biological Evaluation of Water-Soluble Hybrid Molecules Containing Two Pyrazole Analogues of the Alkylating Cyclopropylpyrroloindole (CPI) Subunit of the Antitumor Agent CC-1065 and Polypyrrole Minor Groove Binders. 153
Adenosine receptors and human melanoma 153
3,5-Disubstituted isoxazoles as synthons for (±)-pyrenophorin and (±)-vermiculine synthesis. 152
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 152
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 151
DNA minor groove binders as potential antitumor and antimicrobial agents 150
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 150
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 150
Active γ-manganese dioxide promoted conversion of 4,5-dihydro-1,2-oxazoles to 1,2-oxazoles. 150
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 150
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 150
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 149
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 149
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 148
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 148
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 148
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 148
Methyl 4-oxothiolane-3-carboxylate and methyl 2-methyl-4-oxothiolane-3- carboxylate anions as synthetic equivalents of α-acrylate and α-crotonate anions. Formal synthesis of integerrinecic acid 147
Ethyl 2,4-dioxoalkanoates as starting materials for a convenient route to 3(2H)-furanones and 3(2H)-furanimines 147
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 147
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 147
A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol 147
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 146
2,3a,5,6,7,7a-Hexahydro-3H,4H-benzothiophene-3,4-dione and cyclopenta[b]tetrahydrothiophene-3,4-dione enolate anions as synthetic equivalents to cyclohex-2-enone and cyclopent-2-enone C-2-carbanions. 145
2-Arylamino-4-Amino-5-Aroylthiazoles. "One-Pot" Synthesis and Biological Evaluation of a New Class of Inhibitors of Tubulin Polymerization. 145
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 144
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies 144
A [3 + 2] nitrile oxide cycloaddition approach to retinoids 143
Current status of A1 adenosine receptor allosteric enhancers 143
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 143
Geiparvarin Analogs. 4.1. Synthesis and Cytostatic Activity of Geiparvarin Analogs Bearing a Carbamate Moiety or a Furocoumarin Fragment on the Alkenyl Side Chain 142
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 142
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 142
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 142
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 142
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds 141
Hybrid molecules based on distamycin A as potential antitumor agents 141
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 140
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 140
Allosteric modulators for the A1-adenosine receptor 139
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 139
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 138
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 137
A new direct glycosylation of pyrimidine, pyrazole, imidazole and purine heterocycles via their N-tetrahydropyranyl (THP) derivatives 137
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 136
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 136
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 136
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 136
A new nitrile oxide based synthesis of the antitumor agent geiparvarin 135
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 135
Synthesis of 2-(5-substituted isoxazol-3-yl)-4-oxo-3-thiazolidinyl alkanoic acids 134
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 134
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 134
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 133
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 132
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 132
Recent improvements in the development of A2B adenosine receptor agonists 130
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 130
Synthesis and cytotoxic activity of 6-vinyl- and 6-ethynyluridine and 8-vinyl- and 8-ethynyladenosine 129
Synthesis of syn- and anti-tricyclo[4.1.0.02,4]heptan-5-ones and related compounds. 129
Synthesis of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine and 1,2,3-triazolo[4,5-e]1,2,4-triazolo[1,5-c]pyrimidine displaying potent and selective activity as A2a adenosine receptor antagonists 129
Total synthesis of (±)-isoclovene. 129
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 129
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 129
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 129
A new simple synthesis of a-substituted acrylonitriles 129
A one-pot glycosylation of tetrahydropyranyl (THP) ether intermediates 128
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 128
Synthesis of 6‐substituted‐4,5‐dihydro‐3(2H)‐pyridazinones 127
Preparation of 3,4-dihydroxy-1-benzeneethanol: a reinvestigation 127
Stereospecific nitromethane conjugate addition to 4-oxygenated 2-substituted cyclopent-2-enones: a simple approach to prostaglandins. 127
Synthesis and antitumor activity of novel distamycin derivatives 127
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 126
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 126
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 126
Pyrazole-Related Nucleosides. Synthesis and Antiviral/Antitumor Activity of Some Substituted Pyrazole and Pyrazolo[4,3-d]-1,2,3-triazin-4-one Nucleosides 125
Allosteric enhancers for A(1) adenosine receptor 125
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D 1 or D2 dopamine receptor agonists 125
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 125
Totale 15.201
Categoria #
all - tutte 212.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.190
Totale 214.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.127 0 0 0 0 0 0 0 875 643 1.046 409 154
2020/20216.321 641 592 270 697 298 649 146 728 122 786 837 555
2021/20225.107 159 470 374 291 374 252 208 244 198 362 528 1.647
2022/20234.812 509 249 108 647 884 775 145 392 614 31 286 172
2023/20242.417 243 309 129 82 170 287 95 398 28 60 56 560
2024/20254.219 292 299 752 335 1.156 772 274 339 0 0 0 0
Totale 47.619